Evidence map›Paper›PMID 25219528›Full record

ArticleInternational journal of obesity (2005)2015

L-cysteine suppresses ghrelin and reduces appetite in rodents and humans.

A K McGavigan, H C O'Hara, A Amin, J Kinsey-Jones, E Spreckley, A Alamshah, A Agahi, K Banks, R France, G Hyberg and 8 more

Open access · hybridAbstract read
In one paragraph

Article in International journal of obesity (2005), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 41 citations in OpenAlex.

  1. Trial
  2. Sulfide regulation and catabolism in health and disease.Signal transduction and targeted therapy · 2025
    Review
  3. Review
  4. Review
  5. Gut peptides and the microbiome: focus on ghrelin.Current opinion in endocrinology, diabetes, and obesity · 2021
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 2 countries.

A K McGaviganDepartment of Investigative Medicine, Imperial College London, London, UK.
H C O'HaraDepartment of Investigative Medicine, Imperial College London, London, UK.
A AminDepartment of Investigative Medicine, Imperial College London, London, UK.
J Kinsey-JonesDepartment of Investigative Medicine, Imperial College London, London, UK.
E SpreckleyDepartment of Investigative Medicine, Imperial College London, London, UK.
A AlamshahDepartment of Investigative Medicine, Imperial College London, London, UK.
A AgahiDepartment of Investigative Medicine, Imperial College London, London, UK.
K BanksDepartment of Investigative Medicine, Imperial College London, London, UK.
R FranceDepartment of Investigative Medicine, Imperial College London, London, UK.
G HybergAstraZeneca R&D, Mölndal, Sweden.
C WongDepartment of Investigative Medicine, Imperial College London, London, UK.
G A Bewick1] Department of Investigative Medicine, Imperial College London, London, UK [2] Division of Diabetes & Nutritional Sciences, King's College London, London, UK.
J V GardinerDepartment of Investigative Medicine, Imperial College London, London, UK.
A Lehmann1] AstraZeneca R&D, Mölndal, Sweden [2] NextRx, Gothenburg, Sweden.
N M MartinDepartment of Investigative Medicine, Imperial College London, London, UK.
M A GhateiDepartment of Investigative Medicine, Imperial College London, London, UK.
S R BloomDepartment of Investigative Medicine, Imperial College London, London, UK.
K G MurphyDepartment of Investigative Medicine, Imperial College London, London, UK.
Imperial College London · GBAstraZeneca (Sweden) · SEKing's College London · GB

Funding

Biotechnology and Biological Sciences Research Council BB/E52708X/1Biotechnology and Biological Sciences Research Council BB/I001816/1Biotechnology and Biological Sciences Research Council BB/I00842X/1Department of Health CDF-2011-04-006Medical Research Council MR/J010944/1National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/K500379/1Wellcome TrustWellcome Trust FP7- HEALTH-2009-241592
6 · The paper itself

Abstract

backgroundHigh-protein diets promote weight loss and subsequent weight maintenance, but are difficult to adhere to. The mechanisms by which protein exerts these effects remain unclear. However, the amino acids produced by protein digestion may have a role in driving protein-induced satiety.

methodsWe tested the effects of a range of amino acids on food intake in rodents and identified l-cysteine as the most anorexigenic. Using rodents we further studied the effect of l-cysteine on food intake, behaviour and energy expenditure. We proceeded to investigate its effect on neuronal activation in the hypothalamus and brainstem before investigating its effect on gastric emptying and gut hormone release. The effect of l-cysteine on appetite scores and gut hormone release was then investigated in humans.

resultsl-Cysteine dose-dependently decreased food intake in both rats and mice following oral gavage and intraperitoneal administration. This effect did not appear to be secondary to behavioural or aversive side effects. l-Cysteine increased neuronal activation in the area postrema and delayed gastric emptying. It suppressed plasma acyl ghrelin levels and did not reduce food intake in transgenic ghrelin-overexpressing mice. Repeated l-cysteine administration decreased food intake in rats and obese mice. l-Cysteine reduced hunger and plasma acyl ghrelin levels in humans.

conclusionsFurther work is required to determine the chronic effect of l-cysteine in rodents and humans on appetite and body weight, and whether l-cysteine contributes towards protein-induced satiety.

Indexed as

AdultAnimalsAppetiteAppetite DepressantsCysteineDose-Response Relationship, DrugEatingFemaleGastrointestinal HormonesGhrelinHumansHypothalamusMaleMiceMice, Inbred C57BLRatsAppetite DepressantsCysteineGastrointestinal HormonesGhrelinReceptors, Gastrointestinal HormoneReceptors, NeuropeptideRNA, Messenger

Identifiers

PMID25219528
PMCPMC4276721
OpenAlexW2010405389

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.